You are here

Initiating Treatment

Active Resources: 11

  • These presentation slides were from an annual event presented by the Pacific AETC's Arizona regional partner, California Prevention Training Center, and Curry International TB Center for

    Type: Training Materials
    Publish Date: 7/29/2021
  • To help HIV care providers engage patients in care and transmission prevention, the Centers for Disease Control and Prevention (CDC) developed a new and comprehensive Prevention IS Care re

    Type: Clinical Reference Tools
    Publish Date: 6/30/2021
  • Training slides covering U.S. HHS treatment recommendations related to starting antiretroviral therapy (ART) in people with HIV infection.

    Type: Training Materials
    Publish Date: 6/10/2021
  • Immediate antiretroviral therapy (ART) means starting HIV treatment as soon as possible after the diagnosis of HIV infection, preferably on the first clinic visit (and even on the same day as the H

    Type: Guidelines
    Publish Date: 6/10/2021
  • Excerpt from the Guidelines Introduction: "The Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) is a working group of

    Type: Guidelines
    Publish Date: 6/3/2021
    Review Date: 7/5/2021
  • The HIV epidemic is an important public health priority. Transmissions continue to occur despite effective therapies that make HIV preventable and treatable.

    Type: Articles, Reports, and Manuals
    Publish Date: 4/15/2021
  • The National HIV Curriculum (NHC) provides free, up-to-date content for clinicians to learn about HIV diagnosis, treatment, and prevention.

    Type: Online and Self-Paced Learning
    Publish Date: 9/14/2020
    Review Date: 9/8/2021
  • Slides from a 1-day course for primary care physicians and mid-level clinicians, which combines the latest research with current treatment guidelines for managing patients with HIV.

    Type: Online and Self-Paced Learning
    Publish Date: 7/31/2020
  • Each year HRSA's HIV/AIDS Bureau sponsors a conference for Ryan White Program clinicians to learn about advances in care and treatment.

    Type: Online and Self-Paced Learning
    Publish Date: 12/4/2019
  • In response to newly identified, community-based HIV epidemics, the AETC NCRC has pulled together the following AETC Program and U.S.

    Type: Clinical Reference Tools
    Publish Date: 6/10/2019
  • This glossary of HIV/AIDS-related terms includes brief lay-oriented descriptions and illustrations. Materials are in the public domain and may be used freely.

    Type: Clinical Reference Tools
    Publish Date: 2/20/2019
    Review Date: 2/20/2019

Archive Resources: 3

Articles: 4

  • FDA Approves 2-Drug Combination of Dolutegravir + Lamivudine

    Susa Coffey's picture

    In April 2019, the U.S. Food and Drug Administration approved a combination pill comprising the integrase inhibitor dolutegravir (DTG), 50 mg, and the NRTI lamivudine (3TC), 300 mg, for use as a complete ARV regimen for initial HIV treatment of patients. The approval specifies that DTG/3TC is...

  • Doravirine in Initial Therapy: DRIVE-AHEAD Study

    Susa Coffey's picture

    Doravirine (DOR) is an investigational NNRTI that currently is being developed in a coformulation with TDF and FTC. A Phase 3 comparison of DOR + 2 NRTIs (87% of study subjects were given TDF/FTC) and DRV/r + 2 NRTIs in initial therapy was presented at CROI earlier this year (DRIVE-FORWARD); the...

  • Bictegravir in Initial Therapy

    Susa Coffey's picture

    Bictegravir (BIC) is an investigational integrase inhibitor that is being studied as part of a coformulation with tenofovir alafenamide (TAF) and emtricitabine (FTC). Two Phase 3 trials comparing a single-tablet regimen of BIC/TAF/FTC (50/25/200 mg) with regimens containing dolutegravir (DTG)...

  • START-ing TEMPRANO: Early Initiation of Antiretroviral Therapy for HIV

    Jennifer Cocohoba's picture

    The prevailing opinion among experts regarding the optimal CD4 T-cell count at which to start patients on antiretroviral therapy (ART) has shifted several times during the evolution of HIV treatment. These shifts reflect attempts to strike a balance between preventing HIV-associated illness and...